T. McNeely

发表

Effect of individual conjugate dose on immunogenicity of type 6B pneumococcal polysaccharide-N. meningitidis outer membrane protein complex conjugate vaccines in infant rhesus monkeys.

J. Donnelly, T. McNeely, X. Liu, 2000, Vaccine.

Naturally occurring IgG antibody levels to the Staphylococcus aureus protein IsdB in humans

D. Ala'aldeen, B. Kreiswirth, A. Anderson, 2013, Human vaccines & immunotherapeutics.

Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model

R. Proctor, L. Cope, A. Joshi, 2012, Human vaccines & immunotherapeutics.

Development of a rat central venous catheter model for evaluation of vaccines to prevent Staphylococcus epidermidis and Staphylococcus aureus early biofilms

L. Cope, J. Antonello, A. Meinke, 2011, Human vaccines.

Bacteria Immunoglobulin‐Binding Proteins: Biology and Practical Applications

L. Cope, T. McNeely, 2009 .

A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo.

Charles Y. Tan, A. Finnefrock, Victoria Towne, 2010, Human antibodies.

Antibody Responses to Capsular Polysaccharide Backbone and O-Acetate Side Groups of Streptococcus pneumoniae Type 9V in Humans and Rhesus Macaques

J. Donnelly, M. Blum, T. McNeely, 1998, Infection and Immunity.

Development of an opsonin inhibition assay for evaluation of complex polysaccharide protective epitopes.

J. Donnelly, J. Sadoff, A. Cross, 2006, Vaccine.

. in Humans and Rhesus Macaques Type 9 V Streptococcus pneumoniae Groups of Polysaccharide Backbone and O-Acetate Side Antibody Responses to Capsular

J. Donnelly, M. Blum, T. McNeely, 1998 .

A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers.

R. Dagan, V. Pinsk, P. Mendelman, 2000, Vaccine.

Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: An analysis of possible contributing host factors

Najaf A. Shah, A. Joshi, F. Lupu, 2014, Human vaccines & immunotherapeutics.

Coincident Light/ultrasound therapy to treat bacterial biofilms

M. Schafer, T. McNeely, 2015, 2015 IEEE International Ultrasonics Symposium (IUS).

A fully human monoclonal antibody to Staphylococcu saureu siro nregulate dsurface determinant B (IsdB) with functional activity i nvitr oan di nvivo

Charles Y. Tan, A. Finnefrock, Victoria Towne, 2010 .

Characterization of the mechanism of protection mediated by CS-D7, a monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB)

L. Cope, D. Montgomery, Hong-xia Fan, 2012, Front. Cell. Inf. Microbio..

Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphosphatidylinositol antigens of the protozoan parasite Leishmania.

S. Turco, T. McNeely, G. Rosen, 1989, The Biochemical journal.

Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus.

K. Jansen, Qiuwei Xu, G. Pier, 2003, Carbohydrate research.

Stable DNA transfection of a wide range of trypanosomatids.

S. Beverley, C. Coburn, S. Turco, 1991, Molecular and biochemical parasitology.

Inhibition of protein kinase C activity by the Leishmania donovani lipophosphoglycan.

S. Turco, T. McNeely, T. Mcneely, 1987, Biochemical and biophysical research communications.

Characterization of Leishmania donovani variant clones using anti-lipophosphoglycan monoclonal antibodies.

T. Pearson, S. Turco, T. McNeely, 1990, Glycobiology.

Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes.

S. Turco, T. McNeely, S J Turco, 1990, Journal of immunology.

A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection.

Steven L. Cohen, A. Woods, K. Jansen, 2006, Vaccine.

Combining Visible Light and Non-Focused Ultrasound Significantly Reduces Propionibacterium acnes Biofilm While Having Limited Effect on Host Cells

M. Schafer, T. McNeely, T. Mcneely, 2021, Microorganisms.

Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.

R. Betts, V. Fowler, Y. Carmeli, 2013, JAMA.

A Novel Staphylococcus aureus Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine S. aureus Sepsis Model

Charles Y. Tan, W. Mcclements, K. Jansen, 2006, Infection and Immunity.

Selection and Characterization of Murine Monoclonal Antibodies to Staphylococcus aureus Iron-Regulated Surface Determinant B with Functional Activity In Vitro and In Vivo

A. Finnefrock, Qinjian Zhao, Victoria Towne, 2009, Clinical and Vaccine Immunology.

Kartsonis and Mark T. Esser Serologic Assay to Quantify Human

L. Cope, M. Esser, A. Anderson, 2009 .

Titrating T‐Cell Epitopes within Self‐Assembled Vaccines Optimizes CD4+ Helper T Cell and Antibody Outputs

Arthur Fridman, Joel H Collier, Huifang Han, 2014, Advanced healthcare materials.

Developing a Universal Staphylococcus aureus Vaccine: Why Aren’t We There Yet?

A. Joshi, T. McNeely, T. Mcneely, 2013 .

Staphylococcus aureus capsule type 8 antibodies provide inconsistent efficacy in murine Models of staphylococcal infection

Charles Y. Tan, J. Joyce, L. Cope, 2009, Human vaccines.

Inhibition of protein kinase C activity by the Leishmania donovani lipophosphoglycan.

S. Turco, T. McNeely, 1987, Biochemical and biophysical research communications.

Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.

J. Orenstein, S. Wahl, S. Eisenberg, 1997, The American journal of pathology.

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.

D. Dripps, J. Orenstein, S. Wahl, 1995, The Journal of clinical investigation.

Isolation of Lipophosphoglycans fromLeishmania donovaniAmastigotes

T. McNeely, P. Doyle, 1996 .

Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.

S. Wahl, L. Wahl, D. Dewitt, 1997, The Journal of clinical investigation.

Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription.

S. Wahl, S. Eisenberg, D. Shugars, 1997, Blood.